After MRNA , PFE , AZE's great vaccine trial result, the group has gained momentum today. The market is optimistic about NVAX's coming result and pushed price above pivot $113. The 4 month correction of 59% is finished and there is a chance for NVAX to challenge previous high at $188 if the vaccine result is good. However, it is a risky bet since the vaccine trial result is not out yet. Should buy with cautious. My recommendation is to limit risk by using bull spread strategy. For example: buy $135 call @ $11 + Sell $165 call @ $5 with total cost of $6; The max profit is $2400 and max loss is $600 Or buy the stock at $120 with SL at $100 and 1st TP at $150, 2nd PT at $188.